Nuformix (NFX)

Sector:

Pharma and Biotech

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

8.25p
   
  • Change Today:
    -0.25p
  • 52 Week High: 13.75
  • 52 Week Low: 1.95
  • Currency: UK Pounds
  • Shares Issued: 460.75m
  • Volume: 2,137,806
  • Market Cap: 38.01m
  • RiskGrade: 522
  • Beta: 0.06

Nuformix Overview

Nuformix is in the pharma and biotech sector and is currently trading at 8.25p per share. In the last year Nuformix's share price has ranged from 1.95p to 13.75p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -296.7% n/a
ROCE 431.0%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 62.3 n/a
Pr/Book 10.0  
Latest F'cast
Revenue 6000.0% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Nuformix Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-16 n/a (0.35) (0.58)p n/a n/a n/a n/a 0.0%
31-Mar-17 n/a (0.36) (0.10)p n/a n/a n/a n/a 0.0%
31-Mar-18 0.01 (1.97) (0.49)p n/a n/a n/a n/a 0.0%
31-Mar-19 0.61 (1.84) (0.36)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Nuformix Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-20 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Nuformix Company Announcements

Annual Financial Report 01-Aug-2019 09:30 RNS
Holding(s) in Company 29-Jul-2019 07:00 RNS
Final Results 18-Jul-2019 07:00 RNS

Latest Nuformix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Nuformix Market Data

Currency UK Pounds
Share Price 8.25p
Change Today -0.25p
% Change -2.94 %
52 Week High 13.75
52 Week Low 1.95
Volume 2,137,806
Shares Issued 460.75m
Market Cap 38.01m
Beta 0.06
RiskGrade 522

Nuformix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.7% below the market average45.7% below the market average45.7% below the market average45.7% below the market average45.7% below the market average
22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average
Price Trend
99.50% above the market average99.50% above the market average99.50% above the market average99.50% above the market average99.50% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
23.44% above the market average23.44% above the market average23.44% above the market average23.44% above the market average23.44% above the market average
31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average

Nuformix Dividends

No dividends found

Trades for 22-Aug-2019

Time Volume / Share Price
17:10 90,000 @ 8.25p
16:18 10,693 @ 8.03p
15:59 45,751 @ 8.25p
15:50 45,391 @ 8.06p
15:47 139,884 @ 8.00p

Nuformix Key Personnel

CEO Pascal Hughes
CEO Daniel Gooding

Top of Page